Mucormycosis or the grimmer popular name, Black Fungus has evoked public concern in the context of the COVID-19 pandemic but the disease is not that uncommon, medical literature from India shows. Mucormycosis is an angioinvasive disease caused by saprophytic fungi of the order Mucorales. Rare, life threatening COVID-19 complications appear to be escalating in India, creating a fresh wave of critical medical challenges in a country that has already seen short supplies of oxygen and other basic needs. Hospital across India have been reporting several cases of Mucormycosis, a rare fungal infection, affecting patients who have recently recovered from COVID-19. Once considered a rare “opportunistic” fungal infection in Covid-19 patients, mucormycosis has emerged as a dramatic bellwether for a raft of secondary ailments symptomatic of India’s inability to contain the world’s fastest growing coronavirus outbreak. The exact incidence of mucormycosis in India is unknown due to the lack of population based studies. The estimated prevalence of mucormycosis is around 70 times higher in India than that in global data. Diabetes mellitus is the most common risk factor, followed by haematological malignancy and solid-organ transplant. The government has now declared it a ‘Notifiable Disease’.